Decentralized Clinical Trials (DCTs) are transforming the landscape of clinical research by harnessing digital technologies to facilitate remote patient participation. This patient-centric approach not only benefits participants but also ensures more inclusive and robust study results while reducing the workload for investigators. In the post-pandemic climate, a hybrid model is emerging that seamlessly integrates technology advances with traditional site workflows, creating a new era of clinical trials that harnesses the strengths of both. In a funding-constrained environment, DCT platform providers are looking to strike a balance between client satisfaction and cost reduction. They are focusing on delivering comprehensive solutions that include real-world evidence, integration with sensors and wearables, and tools dedicated to enhancing patient engagement and retention throughout the trial process.

In this report, we assess the capabilities of 22 platform providers specific to the decentralized clinical trial landscape. These platform providers are mapped on the Everest Group PEAK Matrix^® , a composite index of a range of distinct metrics related to a provider’s capability and market impact.

Scope

Industry: Life sciences clinical development technology

Geography: global

Contents

In this report, we:

• Examine the provider landscape for DCTs
• Assess DCT platform providers on several capabilities and market success-related dimensions

Membership(s)

Clinical Development Technology

Sourcing and Vendor Management